GEN Exclusives

More »

New Products

More »
Mar 15, 2014 (Vol. 34, No. 6)

Life Technologies

Click Image To Enlarge +

Transfection Reagent

Lipofectamine® 3000, a reagent for nucleic acid delivery, was designed to enhance transfection efficiency in difficult-to-transfect cells while reducing cytotoxicity-associated cell alteration. The reagent was also designed for versatility—it can work with a broad spectrum of cell lines. Also, a single kit can transfect DNA or RNA or accomplish co-transfection. With this new reagent, GeneArt® TALs and CRISPR can target the AAVS1 locus in HepG2 and U2OS cells, which can improve transfection efficiency, mean fluorescence intensity, and genomic cleavage. These advancements in delivery can help simplify downstream workflows, enable easier stem cell manipulation, and enhance site-specific insertion of transgenes into the cellular genome.

Related To This Company




GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

GEN Poll

More » Poll Results »

Secure Science

Should bans on science education, of the sort imposed on Iranians hoping to study physics and engineering in the United States, encompass other nationals and other fields of study, including biotechnology?